Ajanta Pharma Analysis (March 2026) | Price Target, Growth & Valuation

Ajanta Pharma

NSEI:AJANTPHARM

Rp 2.879,90

Rp0,00 (0,00%)

2.879,90 Rp

Rp0,00 (0,00%)

End-of-day quote: 03/27/2026

Ajanta Pharma Stock Value

Analysts currently rate NSEI:AJANTPHARM as Outperform.

Outperform

Ajanta Pharma Company Info

EPS Growth 5Y

15,39%

Market Cap

Rp359,66 B

Long-Term Debt

Rp0,01 B

Annual earnings

04/30/2026 (E)

Dividend

Rp27,94

Dividend Yield

0,97%

Founded

1973

Industry

Health Care

Country

India

Website

Ajanta Pharma

ISIN Number

INE031B01049

Website

http://www.ajantapharma.com

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Rp3.227,50

12.07%

Last Update: 03/28/2026

Analysts: 12

Highest Price Target Rp3.742,00

Average Price Target Rp3.227,50

Lowest Price Target Rp2.605,00

In the last five quarters, Ajanta Pharma’s Price Target has risen from Rp1.671,38 to Rp1.948,50 - a 16,58% increase. Twelve analysts predict that Ajanta Pharma’s share price will increase in the coming year, reaching Rp3.227,50. This would represent an increase of 12,07%.

Top growth stocks in the health care sector (5Y.)

What does Ajanta Pharma do?

Ajanta Pharma Limited is a prominent player in the pharmaceutical industry, primarily engaged in the formulation, manufacture, and marketing of a wide array of pharmaceutical products. The company has established itself as a significant contributor to the healthcare sector, focusing on both domestic and international markets. The company portfolio includes a diverse line of products, ranging from formulations to custom-made medicines, catering to various therapeutic segments such as cardiology,...

Business Segments

The company operates in multiple business segments, each tailored to meet specific customer needs and regulatory requirements. The company's structure is designed to enhance operational efficiency and market responsiveness.

Formulations: This segment represents the core of the company operations, encompassing a comprehensive range of pharmaceutical products. The company focuses on high-quality formulations across various therapeutic categories. The company employs advanced manufacturing technologies and adheres to stringent quality control measures to ensure that all formulations meet international standards. Research and development play a crucial role in this segment, promoting innovation through the introduction of new products and dosage forms.

Active Pharmaceutical Ingredients (APIs): This segment focuses on the production of essential raw materials utilized for manufacturing pharmaceuticals. The company invests in state-of-the-art technology to ensure the efficacy and safety of its APIs. This segment not only supports the company’s internal requirements but also extends to external markets, catering to other pharmaceutical companies in need of quality APIs.

Biosimilars and Biologics: The company is venturing into the biosimilars market, which involves developing biologics that are closely related to already approved reference products. This expansion aligns with the company strategy to diversify its product offerings and tap into emerging markets.

Consumer Healthcare: The company also engages in the consumer healthcare sector, providing products designed to enhance personal well-being and health management. This segment is gaining traction, with an increasing emphasis on preventive healthcare and self-medication.

International Markets**: The company has established a significant presence in international markets, focusing on regulated regions like the US and Europe. The company tailors its product offerings to meet the specific needs of these markets, ensuring alignment with local regulatory standards.

Business Strategy

The company’s business strategy encompasses a blend of innovation, operational efficiency, and sustainability. The company aims to leverage its strengths in research and development, manufacturing, and market penetration to drive growth and enhance its competitive edge.

The company's strategic focus is on:

Research and Development: Prioritizing R&D efforts remains central to the company strategy. By investing significantly in this area, the company aims to introduce new therapies and formulations, tapping into unmet medical needs while complying with stringent regulatory requirements.

Market Expansion: The company seeks to enhance its footprint in both domestic and international markets. The company targets expansion into emerging markets by identifying key growth opportunities and adapting its offerings to local health needs.

Quality and Compliance: Upholding the highest standards of quality and compliance with regulatory bodies is non-negotiable in the company strategy. The company continually strives to improve its processes and systems to maintain excellence throughout the product lifecycle.

Sustainability: The company recognizes the importance of sustainable practices and is committed to minimizing its environmental impact. The adoption of renewable energy sources and efficient resource management initiatives reflect the company’s dedication to building a greener future.

Partnerships and Collaborations: Strategic partnerships with research organizations and academic institutions play a vital role in the company growth. Collaborations facilitate access to new technologies and markets, underpinning the company’s commitment to innovation.

Products and Services

The company boasts a diverse portfolio of products and services tailored to meet the various needs of healthcare providers and patients. The company's offerings include:

Pharmaceutical Formulations: The core product line includes various dosage forms, including tablets, capsules, injectables, and ointments. Each product is developed with an emphasis on efficacy and safety.

OTC Products: The company also focuses on over-the-counter products that are easily accessible to consumers for managing common ailments.

Therapeutic Areas: The company is involved in multiple therapeutic segments such as cardiology, dermatology, ophthalmology, pain management, and gynecology, offering specialized products designed for each area.

Patient-Centric Solutions: The company emphasizes delivering value-added services, ensuring comprehensive solutions that enhance patient care quality. This includes educational resources and support aimed at promoting better health outcomes.

Export Services: The company extends its reach internationally, providing high-quality pharmaceuticals to various overseas markets, fulfilling specific regulatory and customer requirements.

Overall, the company commitment to quality, innovation, and patient-centric solutions underpins its extensive product and service range, establishing it as a formidable player in the pharmaceutical industry.

Geographical Markets

The company has a diverse geographical reach, catering to both domestic and international markets. The company is significantly present in India, which serves as its primary market, along with a wide-ranging international footprint across multiple countries.

Domestic Market: Within India, the company maintains a robust distribution network, making its pharmaceutical products widely accessible to healthcare providers and patients alike.

International Markets: The company has successfully expanded its operations into various international markets, focusing on regions with high growth potential. This includes countries in North America, Europe, Asia, Africa, and Latin America.

Regulatory Markets: The company emphasizes compliance with international regulatory standards, enabling it to participate actively in regulated markets such as the United States and Europe, where it has established substantial market presence.

Emerging Markets: The company is strategically targeting emerging markets where demand for affordable and quality healthcare products is on the rise. The company invests in market research to understand local dynamics and consumer needs.

Seasonality

The company operates in a relatively stable market, but like many other pharmaceutical entities, it experiences some seasonality in its business operations. Certain therapeutic areas, such as those related to allergy treatments or respiratory conditions, may see increased demand during specific seasons, such as winter or spring.

Customers

The company serves a diverse customer base, which includes healthcare practitioners, hospitals, distributors, and retail pharmacies. The company focuses on ensuring that its products are available to a broad range of healthcare professionals and institutions.

Healthcare Professionals: Doctors and specialists across various therapeutic areas constitute a primary customer category. The company engages with medical professionals through educational programs to promote its products and ensure informed prescribing practices.

Pharmacies and Distributors: The company maintains relationships with numerous pharmacies and distributors, facilitating an extensive distribution network that ensures accessibility and availability of its products.

Hospitals and Clinics: The company collaborates with hospitals and clinics, providing products used in patient treatment and care. This relationship often includes direct supply agreements and educational initiatives to enhance product utilization.

Customer Base Size: The company serves thousands of customers across its operational geographies, ensuring comprehensive engagement and support for all stakeholders involved in patient health management.

Distribution Channels

The company employs diverse marketing and distribution channels to reach its customer base effectively. The company's approach includes:

Direct Sales Force: The company has a dedicated sales force that actively interacts with healthcare professionals to promote products and gather feedback.

Digital Marketing Strategies: The company leverages digital marketing tools to create awareness about its products and engage effectively with its audience.

Collaborative Networks: Partnerships with distributors and wholesalers help in expanding market reach and enhancing product visibility across various geographies.

Market Segmentation: The company segments its marketing efforts according to therapeutic areas, customer preferences, and regional needs, ensuring tailored solutions for different markets.

In summary, the company marketing and distribution channels reflect a strategic emphasis on customer engagement and product accessibility, facilitating its growth in the competitive pharmaceutical landscape.

History

Ajanta Pharma Limited was founded in 1973. The company was incorporated in 1979.

Ajanta Pharma Questions and Answers

Which sectors generate sales and which are the top 3 markets?

**Pharmaceutical Sales:** 100% (2025) **TOP 3 Markets:** 1. **India:** approx. 35% 2. **USA:** approx. 25% 3. **Africa:** approx. 20% Ajanta Pharma Limited generates its sales entirely from the pharmaceutical industry. The company has a strong presence in several international markets. The domesti...

At which locations are the company’s products manufactured?

**Production sites of Ajanta Pharma Limited:** 1. **India:** - Dahej, Gujarat - Paithan, Maharashtra - Chikalthana, Maharashtra - Guwahati, Assam Ajanta Pharma Limited operates multiple production facilities in India specializing in the manufacturing of pharmaceutical products. These s...

What strategy does Ajanta Pharma pursue for future growth?

**Focus on international markets:** Ajanta Pharma has strengthened its presence in over 30 countries. **Research and Development:** Investments in R&D account for approximately 7-8% of revenue. **Product diversification:** Introduction of new products in the fields of ophthalmology, dermatolog...

Which raw materials are imported and from which countries?

**Main raw materials:** Active Pharmaceutical Ingredients (APIs), excipients, packaging materials **Countries of origin:** China, India, Europe Ajanta Pharma Limited mainly imports Active Pharmaceutical Ingredients (APIs) needed for the production of its pharmaceutical products. A large portion of...

How strong is the company’s competitive advantage?

**Market share in India:** 2.5% (2024, estimated) **Export share of revenue:** 40% (2024) **R&D expenses:** 7% of revenue (2024) Ajanta Pharma Limited has gained a significant competitive advantage through its strong presence in emerging markets and its specialization in niche markets. The...

What is the share of institutional investors and insider buying/selling?

**Institutional Investor Share:** 25% (estimated for 2025 based on historical data) **Insider Buys/Sells:** No significant transactions in the last 12 months (estimated for 2025) The institutional investor share in Ajanta Pharma Limited is estimated to be around 25%. This indicates a moderate inte...

What percentage market share does Ajanta Pharma have?

**Market share of Ajanta Pharma Limited:** Estimated 3-5% (2025) **Top competitors and their estimated market shares:** 1. **Sun Pharmaceutical Industries:** 8-10% 2. **Dr. Reddy's Laboratories:** 7-9% 3. **Cipla Limited:** 6-8% 4. **Lupin Limited:** 5-7% 5. **Aurobindo Pharma:** 4-6% 6. **Zyd...

Is Ajanta Pharma stock currently a good investment?

**Revenue Growth:** 11.5% (2024) **Profit Growth:** 9.8% (2024) **Research and Development (R&D) Expenses:** 7.2% of revenue (2024) Ajanta Pharma Limited recorded a solid revenue growth of 11.5% in 2024. This indicates that the company is able to maintain or even expand its market share. The pr...

Does Ajanta Pharma pay a dividend – and how reliable is the payout?

**Dividend Yield:** 0.8% (estimated for 2025) **Dividend History:** Continuous payout over the last 5 years Ajanta Pharma Limited regularly pays dividends to its shareholders. The dividend yield is estimated to be 0.8% for the year 2025. Over the past five years, the company has consistently dist...

New support ticket

Explore

Ajanta Pharma Stock Value

Ajanta Pharma Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Ajanta Pharma do?

Ajanta Pharma Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

Ajanta Pharma Stock Value

Ajanta Pharma Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Ajanta Pharma do?

Ajanta Pharma Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.